# The Role of Lifestyle Factors in Multiple Sclerosis: An Integrative Perspective

**Authors:** Roberta Lanzillo, Marinella Clerico, Saverio Stranges

PMC · DOI: 10.3390/brainsci16020224 · Brain Sciences · 2026-02-13

## TL;DR

This paper reviews how lifestyle factors like diet, sleep, and exercise influence multiple sclerosis, highlighting their impact on immune and metabolic health.

## Contribution

The paper integrates findings on lifestyle factors and MS, identifying shared biological pathways and suggesting lifestyle counseling as a complementary treatment strategy.

## Key findings

- Obesity during adolescence increases MS risk through immunometabolic mechanisms.
- Sleep disturbances contribute to neuroinflammation and cognitive dysfunction in MS.
- Smoking accelerates disability progression, while alcohol's effects are dose-dependent.

## Abstract

Multiple sclerosis (MS) is a chronic, immune-mediated neurological disorder characterized by inflammation, demyelination, and progressive neurodegeneration. While genetic susceptibility contributes to disease risk, a growing body of evidence highlights the crucial role of modifiable lifestyle factors in influencing MS onset, disease activity, progression, and overall quality of life. In this narrative review, we explored the relevant literature from commonly used datasets (PubMed, Scopus, Google Scholar), using search terms such as “Lifestyle and Multiple Sclerosis”, “Diet and Multiple Sclerosis”, “Sleep and Multiple Sclerosis”, “Alcohol consumption and Multiple Sclerosis”, and “Physical Activity and Multiple Sclerosis”. Obesity, particularly during adolescence, has emerged as a significant risk factor for MS, acting through immunometabolic mechanisms such as chronic low-grade inflammation, insulin resistance, and dysregulated adipokine signaling. Sleep disturbances are increasingly recognized as contributors to neuroinflammation and cognitive dysfunction, potentially mediated by impaired glymphatic clearance. Smoking is consistently associated with accelerated disability progression, while alcohol consumption shows dose-dependent effects, with excessive intake negatively impacting sleep and glymphatic function. Overall, lifestyle factors converge on shared biological pathways involving immune regulation, metabolic health, vascular integrity, and glymphatic function. Integrating evidence-based lifestyle counseling with disease-modifying therapies may represent a complementary strategy to optimize long-term outcomes in people with MS, while highlighting key areas for future translational and clinical research.

## Linked entities

- **Diseases:** Multiple Sclerosis (MONDO:0005301)

## Full-text entities

- **Genes:** AQP4 (aquaporin 4) [NCBI Gene 361] {aka MIWC, MLC4, WCH4, hAQP4}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Diseases:** sleep disruption (MESH:D019958), vascular dysfunction (MESH:D002561), neuroinflammation (MESH:D000090862), atrophy (MESH:D001284), RMS (MESH:D020529), insulin resistance (MESH:D007333), infection (MESH:D007239), insomnia (MESH:D007319), neurotoxic (MESH:D020258), glymphatic impairment (MESH:D060825), brain atrophy (MESH:C566985), immune disorders (MESH:D007154), Sleep disturbances (MESH:D012893), demyelinating disorder (MESH:D003711), inflammation (MESH:D007249), injury to (MESH:D014947), cardiometabolic, neurodegenerative and psychiatric disease (MESH:D019636), disability (MESH:D009069), cognitive dysfunction (MESH:D003072), chronic disease (MESH:D002908), MS (MESH:D009103), neurological disorder (MESH:D009461), clinical (MESH:D000075902), fatigue (MESH:D005221), dysfunction (MESH:D006331), mood disorders (MESH:D019964), axonal degeneration (MESH:D009410), fragmented sleep (MESH:D012892), adiposity (MESH:D018205), Obesity (MESH:D009765)
- **Chemicals:** omega-3 (MESH:D015525), poly-phenolic phytochemical (-), vitamin D (MESH:D014807), DMT (MESH:D004130), curcumin (MESH:D003474), nitric oxide (MESH:D009569), Alcohol (MESH:D000438)
- **Species:** Homo sapiens (human, species) [taxon 9606], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938701/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938701/full.md

---
Source: https://tomesphere.com/paper/PMC12938701